SR
Siva Rama Prasad Aluru
About Siva Rama Prasad Aluru
Data last updated:
Siva Rama Prasad Aluru is a Managing Director at Credo Life Sciences Private Limited (since 2014), Director at Credo Pharma Private Limited (since 2019) and Designated Partner at Auctus Life Sciences Llp (since 2018). The companies operate in Pharma and Chemicals. The 2 current companies with reported revenue have a combined latest revenue of ₹103 Cr; the largest is Credo Life Sciences Private Limited at ₹100 Cr (FY 2024). Earlier, Siva Rama Prasad Aluru was a Managing Director at Auctus Pharma Limited (2003–2014) and Director at Auctus Life Sciences Limited (2010–2018) and 4 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 03 Jul 2014 | 2014 | ₹100 Cr (FY 2024) | Active | |
| Director | 01 Jul 2019 | 2013 | ₹2.15 Cr (FY 2025) | Active | |
| Designated Partner | 17 Oct 2018 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 03 Nov 2003 | 2000 | Amalgamated | ||
| Director | 02 Feb 2010 | 2010 | Converted To Llp | ||
| Director | 03 Nov 2003 | 1994 | Amalgamated | ||
| Director | 10 Feb 2011 | 2011 | Converted To Llp | ||
| Director | 01 Jul 2014 | 2014 | Strike Off | ||
| Designated Partner | 10 Aug 2016 | 2016 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Siva Rama Prasad Aluru
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aluru Vamsi Krishna | 06572638 | Credo Life Sciences Private Limited , Credo Pharma Private Limited and 1 more | Director |
| Kandru Madhavarao | 06610196 | Credo Life Sciences Private Limited , Credo Pharma Private Limited | Director |
| Aluru Narmada | 07097387 | Credo Pharma Private Limited , Auctus Life Sciences Llp | Director |
| Lakshmi Devi Suryadevara | 06837476 | Auctus Life Sciences Llp | Partner |
| Sreenath Suryadevara | 07234232 | Auctus Life Sciences Llp | Partner |
| Suryadevara Venkateswara Rao | 00363121 | Auctus Life Sciences Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Siva Rama Prasad Aluru
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Siva Rama Prasad Aluru
Siva Rama Prasad Aluru currently holds 3 directorships: Credo Life Sciences Private Limited (Managing Director, since 03 Jul 2014, revenue ₹100 Cr (FY 2024)); Credo Pharma Private Limited (Director, since 01 Jul 2019, revenue ₹2.15 Cr (FY 2025)); Auctus Life Sciences Llp (Designated Partner, since 17 Oct 2018).
Siva Rama Prasad Aluru was first appointed on 03 Nov 2003 as Managing Director at Auctus Pharma Limited. The most recent appointment on record is 01 Jul 2019 at Credo Pharma Private Limited.
The 2 current companies of Siva Rama Prasad Aluru that report revenue have a combined latest revenue of ₹103 Cr: Credo Life Sciences Private Limited ₹100 Cr (FY 2024); Credo Pharma Private Limited ₹2.15 Cr (FY 2025).
Siva Rama Prasad Aluru held 6 earlier board appointments: Auctus Pharma Limited (Managing Director, 03 Nov 2003 to 14 Feb 2014); Auctus Life Sciences Limited (Director, 02 Feb 2010 to 16 Oct 2018); Neo Medichem Private Limited (Director, from 03 Nov 2003); Nvns Laboratories Private Limited (Director, from 10 Feb 2011); Aspen Shaving Products Private Limited (Director, from 01 Jul 2014); and 1 more.
The current boards of Siva Rama Prasad Aluru's companies include Aluru Vamsi Krishna (Credo Life Sciences Private Limited), Kandru Madhavarao (Credo Life Sciences Private Limited), Aluru Narmada (Credo Pharma Private Limited), Lakshmi Devi Suryadevara (Auctus Life Sciences Llp), Sreenath Suryadevara (Auctus Life Sciences Llp), Suryadevara Venkateswara Rao (Auctus Life Sciences Llp).